A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time

NCT07839884 · clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
1360
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer